arrow
E

Evanthia Galanis

Mayo Clinic
H指数:79
被引数:2.7万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Abemaciclib in meningiomas with somatic NF2 or CDK pathway alterations: the phase 2 Alliance A071401 trial

Abemaciclib在具有体细胞NF2或CDK途径改变的脑膜瘤中的应用: 2期联盟A071401试验

2026-01-160
OAAI
Comparison of clinical, radiographic and genomic alterations between histologic and molecular glioblastoma, IDH-wildtype

IDH野生型星形细胞瘤的病理学诊断与分子分型在临床、影像学及基因组学改变方面的比较

2026-01-010
OA
Reflecting on scientific growth and innovation as the Society for Neuro-Oncology turns 30

在神经肿瘤学会成立30周年之际,回顾科学增长与创新

2025-11-040
PRE
Pembrolizumab efficacy in recurrent adult-type diffuse gliomas

帕博利珠单抗在复发成人型弥漫性胶质瘤中的疗效

2025-11-010
OAAI
Clinical utility of RANO 2.0 for response assessment to immunotherapy in recurrent gliomas

RANO 2.0在复发性胶质瘤免疫治疗反应评估中的临床应用价值

2025-11-010
PRE
ALLIANCE A071601: PHASE II TRIAL OF BRAF/MEK INHIBITION IN RECURRENT PAPILLARY CRANIOPHARYNGIOMAS

联盟A071601:BRAF/MEK抑制在复发性乳头状颅咽管瘤中的II期试验

2025-11-010
PRE
WSD0922-FU THERAPY IN PATIENTS WITH EGFR MUTANT GLIOBLASTOMA - UPDATES FROM THE DOSE EXPANSION COHORTS OF A FIRST-IN-HUMAN PHASE 1 CLINICAL TRIAL (MC1914)

WSD0922-FU疗法在EGFR突变型胶质母细胞瘤患者中的应用——来自一项首次人体I期临床试验(MC1914)剂量扩展队列的更新信息

2025-11-010
OAAI
Comparison of clinical, radiographic and genomic alterations between classic and molecular glioblastoma, IDH-wildtype (updated report)

比较经典型与分子型胶质母细胞瘤(IDH野生型)的临床、影像学和基因组改变(更新报告)

2025-11-010
OAAI
RELATIONSHIPS BETWEEN LYMPHOCYTE COUNTS AND CLINICAL OUTCOMES IN PATIENTS WITH GLIOMAS TREATED WITH PEMBROLIZUMAB

胶质瘤患者接受帕博利珠单抗治疗后淋巴细胞计数与临床结局的关系

2025-11-010
OAAI
Dual inhibition of RAF/MEK and FAK signaling improves survival in intracranial meningioma models

RAF/MEK和FAK信号通路的联合抑制可改善颅内脑膜瘤模型的生存率

2025-11-010
OAAI
DIFFERENTIATING ADULT DIFFUSE IDH-MUTANT GLIOMA FROM MOLECULAR GLIOBLASTOMA IDH-WILDTYPE USING DEEP LEARNING ON MRI

利用深度学习在MRI上区分成人弥漫性IDH突变型胶质瘤与分子胶质母细胞瘤IDH野生型

2025-11-010
OAAI
Window of opportunity evaluation of blood-brain barrier permeability heterogeneity within and across high-grade glioma patients

高分级胶质瘤患者内及患者间的血脑屏障通透性异质性窗口期评估

2025-10-010
PRE
Preanalytical variables and analytes in liquid biopsy approach for brain tumors: A comprehensive review and recommendations from the RANO Group and the Brain Liquid Biopsy Consortium

脑肿瘤液体活检方法中的前分析变量和检测物:RANO Group和Brain Liquid Biopsy Consortium的综述与建议

2025-08-010
PRE
Radiation Therapy for WHO Grade 4 Adult-Type Diffuse Glioma: An ASTRO Clinical Practice Guideline

WHO四级成人型弥漫性胶质瘤的放射治疗:ASTRO临床实践指南

2025-06-250
PRE
Considerations on the Application of RANO 2.0 Criteria in Clinical Practice Reply
2024-12-270
PRE